Ming‐Hsin Yeh

453 citations
12 papers · 359 indexed · h-index 10
Topics
HER2/EGFR in Cancer Research (3 papers)Breast Cancer Treatment Studies (2 papers)Cytokine Signaling Pathways and Interactions (2 papers)
Partner nations
TaiwanUnited States

In The Last Decade

Ming‐Hsin Yeh

12 papers receiving 357 citations

Peers

Ming‐Hsin Yeh
Comparison fields: 5 of 57
  • Molecular Biology 223
  • Cancer Research 144
  • Oncology 126
  • Pathology and Forensic Medicine 53
  • Genetics 50
Replace Reyno Del Rosario with:
Reyno Del Rosario United States
Michael Groneberg Germany
Anja Böhnke Germany
Neelakantan Vijayalakshmi India
G Selvaluxmy India
Neele Drobnitzky United Kingdom
Layka Abbasi Asbagh Belgium
Lisa Thelen Germany
Subrata Manna United States
Thanos P. Mourikis United Kingdom
Ming‐Hsin Yeh relative to Reyno Del Rosario United States Reyno Del Rosario's profile →
Citations per field
00.5×1.5×
Reyno Del Rosario · 1×
Citations per year

Countries citing papers authored by Ming‐Hsin Yeh

Since Specialization
Citations

This map shows the geographic impact of Ming‐Hsin Yeh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ming‐Hsin Yeh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ming‐Hsin Yeh more than expected).

Fields of papers citing papers by Ming‐Hsin Yeh

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ming‐Hsin Yeh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ming‐Hsin Yeh. The network helps show where Ming‐Hsin Yeh may publish in the future.

Co-authorship network of co-authors of Ming‐Hsin Yeh

This figure shows the co-authorship network connecting the top 25 collaborators of Ming‐Hsin Yeh. A scholar is included among the top collaborators of Ming‐Hsin Yeh based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ming‐Hsin Yeh. Ming‐Hsin Yeh is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
#WorkIndexed citations
1 2
2 3
3 11
4 18
5 42
6 69
7 34
8 18
9 34
10 61
11 12
12 55

About Ming‐Hsin Yeh

Ming‐Hsin Yeh is a scholar working on Cancer Research, Pathology and Forensic Medicine and Oncology, having authored 12 papers that have together received 359 indexed citations. Recurring topics across this work include HER2/EGFR in Cancer Research (3 papers), Breast Cancer Treatment Studies (2 papers) and Cytokine Signaling Pathways and Interactions (2 papers). The work is most often cited by research in Cancer Research (144 citations), Oncology (126 citations) and Molecular Biology (223 citations). Ming‐Hsin Yeh has collaborated with scholars based in Taiwan and United States. Frequent co-authors include Wei‐Chien Huang, Yun‐Ju Chen, Chih‐Yen Tu, Chia‐Hung Chen, Ya-Ling Wei, Te‐Chun Hsia, Yung‐Luen Yu, Chih‐Hsin Tang, Ju‐Fang Liu and Ming‐Hong Tai. Their work appears in journals such as PLoS ONE, Molecular Pharmacology and Advanced Science.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026